A half-cup serving of canned pineapple (in water) provides an excellent source of vitamin C, per the USDA. Vitamin C is a ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s ...

But just because a company's stock is cheap doesn't mean it is ... that the future will be more bleak than the past. Image ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...

The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...

from questionnaires or by people sending in photos of themselves. The GPhC, which regulates pharmacies, said it was ...

Alcohol consumption in the US is headed for a fourth-straight yearly decline, Bank of America analysts estimated.

The stock is attractively valued at current levels ... but is commonly used off-label for weight loss. Zepbound has the same active ingredient, tirzepatide, but is approved for weight loss ...